To investigate the impact of hematologic toxicity and leukopenia in locally advanced cervical cancer patients undergoing neoadjuvant chemotherapy (NACT).
Chemotherapy-related leukopenia as a biomarker predicting survival outcomes in locally advanced cervical cancer
LEONE ROBERTI MAGGIORE, UMBERTO;
2016-01-01
Abstract
To investigate the impact of hematologic toxicity and leukopenia in locally advanced cervical cancer patients undergoing neoadjuvant chemotherapy (NACT).
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
